Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тетра, СиаfiledCriticalТетра, Сиа
Priority claimed from PCT/LV2010/000007external-prioritypatent/WO2010151095A1/en
Publication of UA106379C2publicationCriticalpatent/UA106379C2/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Novel betaine salts of acetylsalicylic acid, namely 4-trimethylammoniobutanoate acetylsalicylate (meldonium acetylsalicylate), Z-carnitine acetylsalicylate and 3-(trimethylammonioamino)-propanoate (meldonium) acetylsalicylate. Use of meldonium acetylsalicylate as antiplatelet agent for treating various pathologies induced by platelet aggregation, anti-inflammatory and antihyperlipidemic agent.
UAA201200601A2009-06-252010-06-21Meldonium acetylsalicylic acid addition salts and use thereof as a medicinal agent
UA106379C2
(en)
New process for the synthesis of 3-(2-bromo-4,5-dimethoxyphenyl)propanenitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
A NEW METHOD OF SYNTHESIS OF 3- (2-BROM-4,5-DIMETOXYPHENYL) PROPNANITRIL AND THE APPLICATION OF IVARBRADINE AND ITS PHARMACEUTICALLY ACCEPTABLE ACID-SALTES IN SYNTHESIS